| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61269-633-30 | 61269-633 | HUMAN PRESCRIPTION DRUG | Zyprexa | Olanzapine | TABLET | ORAL | 19961001 | N/A | NDA | NDA020592 | H2-Pharma LLC | OLANZAPINE | 10 mg/1 | 30 TABLET in 1 BOTTLE (61269-633-30) |
| 61269-630-30 | 61269-630 | HUMAN PRESCRIPTION DRUG | Zyprexa | Olanzapine | TABLET | ORAL | 19970623 | N/A | NDA | NDA020592 | H2-Pharma LLC | OLANZAPINE | 2.5 mg/1 | 30 TABLET in 1 BOTTLE (61269-630-30) |
| 61269-634-30 | 61269-634 | HUMAN PRESCRIPTION DRUG | Zyprexa | Olanzapine | TABLET | ORAL | 20000110 | N/A | NDA | NDA020592 | H2-Pharma LLC | OLANZAPINE | 15 mg/1 | 30 TABLET in 1 BOTTLE (61269-634-30) |
| 61269-631-30 | 61269-631 | HUMAN PRESCRIPTION DRUG | Zyprexa | Olanzapine | TABLET | ORAL | 19961001 | N/A | NDA | NDA020592 | H2-Pharma LLC | OLANZAPINE | 5 mg/1 | 30 TABLET in 1 BOTTLE (61269-631-30) |
| 61269-635-30 | 61269-635 | HUMAN PRESCRIPTION DRUG | Zyprexa | Olanzapine | TABLET | ORAL | 20010301 | N/A | NDA | NDA020592 | H2-Pharma LLC | OLANZAPINE | 20 mg/1 | 30 TABLET in 1 BOTTLE (61269-635-30) |
| 61269-632-30 | 61269-632 | HUMAN PRESCRIPTION DRUG | Zyprexa | Olanzapine | TABLET | ORAL | 19961001 | N/A | NDA | NDA020592 | H2-Pharma LLC | OLANZAPINE | 7.5 mg/1 | 30 TABLET in 1 BOTTLE (61269-632-30) |